| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $1.19B | $1.05B | $949.7M |
| YoY Revenue Growth % | +13.2% | +10.7% | — |
| Gross Profit | — | — | — |
| Gross Margin % | — | — | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $719.2K | $493.0K | $293.6K |
| Operating Margin % | 0.1% | 0.0% | 0.0% |
| Net Income (GAAP) | $609.5K | $417.8K | $248.8K |
| EBITDA (Normalized) | $43.6M | $38.3M | $34.5M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $878.6M | $749.4M | $617.7M |
| Capital Expenditures (CapEx) | $53.6M | $47.3M | $42.7M |
| Free Cash Flow (FCF) | $825.0M | $702.1M | $575.0M |
| FCF Margin % | 69.3% | 66.8% | 60.5% |
| Return on Invested Capital (ROIC %) | 0.0% | 0.0% | 0.0% |
| Cash & Short-Term Equivalents | $27.0M | $518.3M | — |
| Total Debt (Short + Long Term) | $2.07B | $2.33B | $1.83B |
| Total Stockholders' Equity | $5.18B | $4.54B | $3.75B |